Results 171 to 180 of about 965,316 (341)

Targeting brain, body and heart for cognitive health and dementia prevention [PDF]

This report looks into the current research regarding dementia and Alzheimer\u27s disease prevention and offers ideas for possible future solutions. Prevention of dementia is the ultimate aim of a large, albeit under resourced, international ...
Elodie O', Maree Farrow
core  

Correction to: Post-operative cognitive decline (POCD) after gynaecologic surgery: current opinions and future applications [PDF]

, 2018
Cristina Zarbo, Michela Brivio, Agostino Brugnera, Chiara Malandrino, Gaetano Trezzi, Massimo Rabboni, Emi Bondi, Angelo Compare, Luigi Frigerio   +8 more
openalex   +1 more source

Serum uric acid levels in older adults: Associations with clinical outcomes and implications for reference intervals in those aged 70 years and over

Arthritis Care &Research, Accepted Article.
Objectives Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged 70 and older.
Amanda J Rickard, Cammie Tran, Hans G Schneider, Flavia M Cicuttini, Anita E Wluka, Ego Seeman, Johannes T Neumann, Md Nazmul Karim, Zhen Zhou, Sultana Monira Hussain, David P Q Clark, Daniel Clayton‐Chubb, Andrew M Tonkin, Lawrence J Beilin, Robyn L Woods, John J McNeil   +15 more
wiley   +1 more source

Considerations for Issues of Regression to the Mean and Contextual Effects in Clinical Trials for Pain in Rheumatic Diseases

Arthritis Care &Research, EarlyView.
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen, Guohao Zhu, Afton L. Hassett, Daniel Clauw, Susan L. Murphy   +4 more
wiley   +1 more source

Early Age of Migraine Onset is Independently Related to Cognitive Decline and Symptoms of Depression Affect Quality of Life

, 2020
Jiajia Bao, Mengmeng Ma, Shuju Dong, Lijie Gao, Changling Li, Chaohua Cui, Ning Chen, Yang Zhang, Li He   +8 more
openalex   +1 more source

Exploring patients’ profiles associated with the resolution of acute calcium pyrophosphate arthritis treatedwith colchicine and prednisone: post hoc analysis of a randomized controlled trial

Arthritis Care &Research, Accepted Article.
Objective The objective was to identify factors determining acute arthritis resolution and safety with colchicine and prednisone in acute calcium pyrophosphate (CPP) crystal arthritis. Methods We conducted a post hoc analysis of the COLCHICORT trial, which compared colchicine and prednisone for the treatment of acute CPP crystal arthritis, using a ...
Tristan Pascart, Laurène Norberciak, Pascal Richette, Pierre Robinet, Aurore Pacaud, Gauthier Marchasson, Thibault Rabin, Hélène Luraschi, Pierre Maciejasz, Anne‐France Georgel, Augustin Latourte, Hang‐Korng Ea, Sébastien Ottaviani, Charlotte Jauffret, Vincent Ducoulombier   +14 more
wiley   +1 more source

Parkinson’s disease with mild cognitive impairment may has a lower risk of cognitive decline after subthalamic nucleus deep brain stimulation: A retrospective cohort study

, 2022
Hutao Xie, Quan Zhang, Yin Jiang, Yutong Bai, Jianguo Zhang   +4 more
openalex   +1 more source

The virtual aging brain: a model-driven explanation for cognitive decline in older subjects [PDF]

, 2022
Mario Lavanga, Johanna Stumme, Bahar Hazal Yalçınkaya, J. Fousek, Christiane Jockwitz, Hiba Sheheitli, Nóra Bittner, Meysam Hashemi, Spase Petkoski, Svenja Caspers, Viktor Jirsa   +10 more
openalex   +1 more source

Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue–Related Raynaud Phenomenon in the United States

Arthritis Care &Research, EarlyView.
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech, Charles G. Frech, W. David Merryman, Andrew Sternlicht, Justin Baba   +4 more
wiley   +1 more source

PROGRESSIVE COGNITIVE DECLINE IN ADULTS WITH SICKLE CELL DISEASE (SCD): THE EFFECTS OF THE SOCIOCULTURAL BACKGROUND AND CEREBRAL ATROPHY

, 2020
Bruno Deltreggia Benites, C.M. Silva, Brunno Machado de Campos, P.M. Campos, Samuel Souza Medina, Fernando Cendes, Sara Teresinha Olalla Saad   +6 more
openalex   +1 more source